Tobacco, coffee, and Parkinson's diseaseBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7389.561 (Published 15 March 2003) Cite this as: BMJ 2003;326:561
Caffeine and nicotine may improve the health of dopaminergic systems
- Christopher Martyn, clinical scientist (email@example.com),
- Chris Gale, senior research fellow
- MRC Environmental Epidemiology Unit, Southampton General Hospital, Southampton SO16 6YD
Parkinson's disease belongs to that small group of conditions that occur less often among cigarette smokers than in non-smokers. The observation was first made in a case-control study over 30 years ago,1 but, as Hernán and colleagues have shown in their recent systematic review and meta-analysis,2 the finding has been replicated many times. The protective effect is large—according to the pooled data, current smokers have a 60% reduction in risk compared with those who have never smoked—and consistent between studies in different settings. The fact that two very large prospective studies found a similar reduction in risk to that seen in retrospective studies rules out the possibility that the association can be accounted for by differential survival between smokers and non-smokers.3 Coffee drinking too, seems to protect against Parkinson's disease. Here the pooled estimate is a 30% reduction in risk for coffee drinkers compared with non-drinkers.
In “An Essay on the Shaking Palsy,” …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial